Dave Helsel - Net Worth and Insider Trading

Dave Helsel Net Worth

The estimated net worth of Dave Helsel is at least $739,004 dollars as of 2024-04-30. Dave Helsel is the EVP, Global Manufacturing of Haemonetics Corp and owns about 6,856 shares of Haemonetics Corp (HAE) stock worth over $627,324. Dave Helsel is also the SVP Global Operations and R&D of AngioDynamics Inc and owns about 19,189 shares of AngioDynamics Inc (ANGO) stock worth over $111,680. Details can be seen in Dave Helsel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dave Helsel has not made any transactions after 2023-01-31 and currently still holds the listed stock(s).

Transaction Summary of Dave Helsel

To

Dave Helsel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dave Helsel owns 2 companies in total, including AngioDynamics Inc (ANGO) , and Haemonetics Corp (HAE) .

Click here to see the complete history of Dave Helsel’s form 4 insider trades.

Insider Ownership Summary of Dave Helsel

Ticker Comapny Transaction Date Type of Owner
ANGO AngioDynamics Inc 2023-07-14 SVP Global Operations and R&D
HAE Haemonetics Corp 2013-04-30 VP & Global Manufacturing

Dave Helsel Latest Holdings Summary

Dave Helsel currently owns a total of 2 stocks. Among these stocks, Dave Helsel owns 6,856 shares of Haemonetics Corp (HAE) as of April 30, 2013, with a value of $627,324 and a weighting of 84.89%. Dave Helsel also owns 19,189 shares of AngioDynamics Inc (ANGO) as of January 31, 2023, with a value of $111,680 and a weighting of 15.11%.

Latest Holdings of Dave Helsel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HAE Haemonetics Corp 2013-04-30 6,856 91.50 627,324
ANGO AngioDynamics Inc 2023-01-31 19,189 5.82 111,680

Holding Weightings of Dave Helsel


Dave Helsel Form 4 Trading Tracker

According to the SEC Form 4 filings, Dave Helsel has made a total of 0 transactions in Haemonetics Corp (HAE) over the past 5 years. The most-recent trade in Haemonetics Corp is the acquisition of 272 shares on April 30, 2013, which cost Dave Helsel around $8,903.

According to the SEC Form 4 filings, Dave Helsel has made a total of 5 transactions in AngioDynamics Inc (ANGO) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in AngioDynamics Inc is the sale of 4,633 shares on January 31, 2023, which brought Dave Helsel around $59,997.

Insider Trading History of Dave Helsel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dave Helsel Trading Performance

GuruFocus tracks the stock performance after each of Dave Helsel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dave Helsel is 5.87%. GuruFocus also compares Dave Helsel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dave Helsel within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Dave Helsel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Dave Helsel

Average Return

-12.17%

Average return per transaction

Outperforming Transactions

0%

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.21 5.87 -0.63 -12.17 -0.57 -5.8
Relative Return to S&P 500(%) 2.83 0.11 -11.25 -32.83 -17.16 -16.96

Dave Helsel Ownership Network

Ownership Network List of Dave Helsel

No Data

Ownership Network Relation of Dave Helsel


Dave Helsel Owned Company Details

What does AngioDynamics Inc do?

Who are the key executives at AngioDynamics Inc?

Dave Helsel is the SVP Global Operations and R&D of AngioDynamics Inc. Other key executives at AngioDynamics Inc include director & President and CEO James C Clemmer , SVP/GM & VIT Scott Centea , and SVP International Laura Piccinini .

AngioDynamics Inc (ANGO) Insider Trades Summary

Over the past 18 months, Dave Helsel made 1 insider transaction in AngioDynamics Inc (ANGO) with a net sale of 4,633. Other recent insider transactions involving AngioDynamics Inc (ANGO) include a net purchase of 10,000 shares made by James C Clemmer ,

In summary, during the past 3 months, insiders sold 0 shares of AngioDynamics Inc (ANGO) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 4,633 shares of AngioDynamics Inc (ANGO) were sold and 10,000 shares were bought by its insiders, resulting in a net purchase of 5,367 shares.

AngioDynamics Inc (ANGO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AngioDynamics Inc Insider Transactions

No Available Data

Dave Helsel Mailing Address

Above is the net worth, insider trading, and ownership report for Dave Helsel. You might contact Dave Helsel via mailing address: 400 Wood Road, Braintree Ma 02184.

Discussions on Dave Helsel

No discussions yet.